Effects of oxygen therapy on systemic inflammation and myeloperoxidase modified LDL in hypoxemic COPD patients.
Zouaoui Boudjeltia K, Tragas G, Babar S, Moscariello A, Nuyens V, Van Antwerpen P, Gilbert O, Ducobu J, Brohee D, Vanhaeverbeek M, Van Meerhaeghe A.
Zouaoui Boudjeltia K, et al. Among authors: vanhaeverbeek m.
Atherosclerosis. 2009 Aug;205(2):360-2. doi: 10.1016/j.atherosclerosis.2009.01.028. Epub 2009 Jan 29.
Atherosclerosis. 2009.
PMID: 19230893
No abstract available.